Zhou D - Search Results

1

Combining multi-dimensional data to identify a key signature (gene and miRNA) of cisplatin-resistant gastric cancer.

Zhou D, Li X, Zhao H, Sun B, Liu A, Han X, Cui Z, Yuan L. Zhou D, et al. J Cell Biochem. 2018 Aug;119(8):6997-7008. doi: 10.1002/jcb.26908. Epub 2018 Apr 25. J Cell Biochem. 2018. PMID: 29693274

2

Apoptin-derived peptide reverses cisplatin resistance in gastric cancer through the PI3K-AKT signaling pathway.

Zhou D, Liu W, Liang S, Sun B, Liu A, Cui Z, Han X, Yuan L. Zhou D, et al. Cancer Med. 2018 Apr;7(4):1369-1383. doi: 10.1002/cam4.1380. Epub 2018 Mar 9. Cancer Med. 2018. PMID: 29522284 Free PMC article.

3

Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma.

Han X, Li X, Zhao H, Zhou D, Sun B, Liu A, Zhang J, Cui Z, Ma X, Yuan L. Han X, et al. Among authors: zhou d. J Cell Biochem. 2019 Sep;120(9):15834-15843. doi: 10.1002/jcb.28854. Epub 2019 May 12. J Cell Biochem. 2019. PMID: 31081157

4

A peptide derived from apoptin inhibits glioma growth.

Zhang L, Zhao H, Cui Z, Lv Y, Zhang W, Ma X, Zhang J, Sun B, Zhou D, Yuan L. Zhang L, et al. Among authors: zhou d. Oncotarget. 2017 May 9;8(19):31119-31132. doi: 10.18632/oncotarget.16094. Oncotarget. 2017. PMID: 28415709 Free PMC article.

5

A predictive analysis approach for paediatric and adult high-grade glioma: miRNAs and network insight.

Liu A, Zhao H, Sun B, Han X, Zhou D, Cui Z, Ma X, Zhang J, Yuan L. Liu A, et al. Among authors: zhou d. Ann Transl Med. 2020 Mar;8(5):242. doi: 10.21037/atm.2020.01.12. Ann Transl Med. 2020. PMID: 32309389 Free PMC article.

6

Gene delivery of apoptin-derived peptide using an adeno-associated virus vector inhibits glioma and prolongs animal survival.

Zhong X, Zhao H, Liang S, Zhou D, Zhang W, Yuan L. Zhong X, et al. Among authors: zhou d. Biochem Biophys Res Commun. 2017 Jan 15;482(3):506-513. doi: 10.1016/j.bbrc.2016.10.059. Epub 2017 Feb 3. Biochem Biophys Res Commun. 2017. PMID: 28212737

7

A lower atherogenic index of plasma was associated with a higher incidence of sarcopenia.

Duan Z, Huang Y, Liu X, Tang H, Jiang G, Huang W, Du R, Zhou D, Yang H. Duan Z, et al. Among authors: zhou d. Sci Rep. 2025 Jan 17;15(1):2237. doi: 10.1038/s41598-025-86398-w. Sci Rep. 2025. PMID: 39825028

8

Endogenous hydrogen sulfide persulfidates endothelin type A receptor to inhibit pulmonary arterial smooth muscle cell proliferation.

Zhang Y, Tian X, Chen L, Zhao S, Tang X, Liu X, Zhou D, Tang C, Geng B, Du J, Jin H, Huang Y. Zhang Y, et al. Among authors: zhou d. Redox Biol. 2025 Jan 11;80:103493. doi: 10.1016/j.redox.2025.103493. Online ahead of print. Redox Biol. 2025. PMID: 39823888

9

Dynamic Changes of Late-Onset Cystic Brain Radionecrosis.

Abdulaziz AT, Chen L, He L, Zhou D. Abdulaziz AT, et al. Among authors: zhou d. Neurology. 2025 Feb 25;104(4):e210118. doi: 10.1212/WNL.0000000000210118. Epub 2025 Jan 17. Neurology. 2025. PMID: 39823545 No abstract available.

10

Population pharmacokinetics and exposure-response analysis of durvalumab in combination with gemcitabine and cisplatin in patients with advanced biliary tract cancer.

Abegesah A, Oh DY, Lim K, Fan C, Chen C, Kim C, Wang J, Xynos I, Zotkiewicz M, Ren S, Phipps A, Gibbs M, Zhou D. Abegesah A, et al. Among authors: zhou d. Cancer Chemother Pharmacol. 2025 Jan 17;95(1):23. doi: 10.1007/s00280-024-04743-8. Cancer Chemother Pharmacol. 2025. PMID: 39821700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,369 results

Search Page

Filters